查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1662573

2025 年果凍全球市場報告

Biosurgery Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年果凍市場規模將強勁成長。到 2029 年，這一數字將成長至 229.8 億美元，複合年成長率為 8.7%。預測期內的成長可歸因於組織工程的進步、微創手術的興起、對再生醫學的關注、向生技藥品的轉變以及老齡化社會的需求。預測期內的主要趨勢包括微創手術的增加、整容手術的增加、對幹細胞療法的關注、傷口護理的進步以及生物分解性產品的開發。

預計果凍市場將會成長，這主要歸因於慢性病盛行率的不斷上升。慢性病持續時間超過一年，需要持續的醫療護理，嚴重影響個人的健康並限制他們的日常活動。糖尿病、癌症和心臟病等慢性疾病是美國死亡和殘疾的主要原因。果凍透過移除死組織、降低感染風險和加速癒合過程在治療慢性傷口方面發揮重要作用。例如，根據澳洲統計局2022年3月的數據，78.6%的澳洲人患有至少一種慢性病，佔人口的一半以上。慢性病的增加是推動果凍市場成長的關鍵因素。

推動果凍市場成長的關鍵因素是事故數量的增加。在日常生活、職場、交通和運動等各種情況下，都可能因為不可預見的情況而發生傷害。果凍用於事故場景，以減少出血，促進有效凝血，並加速創傷、損傷和外科手術中的創傷治療。 2022年，澳洲基礎設施、交通、區域發展和通訊部報告道路交通死亡人數為1,194人，與前一年同期比較增加了5.8%。事故數量的增加推動了果凍在傷口有效管理中的應用。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球果凍PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球果凍市場：成長率分析
  • 全球果凍市場表現：規模與成長，2019 年至 2024 年
  • 全球果凍市場預測：規模與成長，2024-2029 年，2034 年預測
  • 全球果凍總目標市場 (TAM)

第6章 市場細分

  • 全球果凍市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 骨移植替代品
  • 軟組織附著物
  • 止血劑
  • 手術密封劑和黏合劑
  • 防沾黏屏障
  • 釘合線加固
  • 全球果凍市場來源、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 天然或生物來源產品
  • 合成產品
  • 全球果凍市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 整形外科
  • 一般外科
  • 神經外科
  • 心血管外科
  • 婦科手術
  • 其他用途
  • 全球果凍市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 其他最終用戶
  • 全球果凍市場，依骨移植替代品類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 人工骨移植
  • 天然骨移植
  • 全球果凍市場細分（按軟組織附件類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 網狀產品
  • 生物移植
  • 全球果凍市場，按止血劑類型細分，性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 粉末
  • 凝膠類藥物
  • 全球果凍市場、外科密封劑和黏合劑細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 纖維蛋白膠
  • 合成密封劑
  • 全球果凍市場，防沾黏屏障細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 吸收屏障
  • 非吸收性屏障
  • 全球果凍市場、釘合線加固細分市場、類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 加固裝置
  • 手術縫合釘

第7章 區域和國家分析

  • 全球果凍市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球果凍市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

  • 果凍市場：競爭格局
  • 果凍市場：公司簡介
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun SE Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Hemostasis LLC Overview, Products and Services, Strategy and Financial Analysis
    • Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Johnson & Johnson Services Inc.
  • CryoLife Inc.
  • CSL Limited
  • Pfizer Inc.
  • Zimmer Biomet Holdings Inc.
  • Kuros Biosciences AG
  • Orthofix Medical Inc.
  • Smiths & Nephew plc
  • Medtronic plc
  • Stryker Corp.
  • Betatech Medical
  • Tissue Regenix Group plc
  • Aroa Biosurgery Ltd.
  • Anika Therapeutics Inc.
  • Arthrex Inc.

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年果凍市場：提供新機會的國家
  • 2029 年果凍市場：細分市場將帶來新機會
  • 2029 年果凍市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第 36 章 附錄

簡介目錄
Product Code: r23208

Biosurgery involves utilizing live maggots to remove dead tissue, minimize infection risks, and accelerate wound healing. This field encompasses semi-synthetic, synthetic, or natural materials that aid in the recuperation of surgical incisions and tissue regeneration.

Primary biosurgery products include bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple line reinforcement. Bone graft substitutes are materials, natural or synthetic, used to fill bone voids and facilitate bone mending. These products stem from natural or biological sources as well as synthetic origins. They find application in orthopedic, general, neurological, cardiovascular, gynecological surgeries, and others, catering to end-users such as hospitals, clinics, and similar facilities.

The biosurgery market research report is one of a series of new reports from The Business Research Company that provides biosurgery market statistics, including biosurgery industry global market size, regional shares, competitors with a biosurgery market share, detailed biosurgery market segments, market trends and opportunities, and any further data you may need to thrive in the biosurgery industry. This biosurgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biosurgery market size has grown strongly in recent years. It will grow from $15.27 billion in 2024 to $16.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing surgical procedures, rise in chronic diseases, growing geriatric population, shift towards biodegradable product, regulatory changes, and approvals.

The biosurgery market size is expected to see strong growth in the next few years. It will grow to $22.98 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to advancements in tissue engineering, rise in minimally invasive procedures, focus on regenerative medicine, shift towards biologics, aging population needs. Major trends in the forecast period include growth in minimally invasive procedures, rise in cosmetic and plastic surgeries, focus on stem cell therapies, advancements in wound care, development of biodegradable products.

The biosurgery market is poised for growth, primarily driven by the increasing prevalence of chronic diseases. Chronic diseases, lasting for a year or longer and requiring ongoing medical care, significantly impact individuals' health, restricting daily activities. In the U.S., chronic diseases such as diabetes, cancer, and heart disease are leading causes of death and disability. Biosurgery plays a crucial role in managing chronic wounds by eliminating dead tissue, reducing infection risk, and expediting the healing process. For example, in March 2022, the Australian Bureau of Statistics reported that 78.6% of Australians suffered from at least one chronic illness, affecting over half of the population. The rise in chronic diseases is a key factor propelling the growth of the biosurgery market.

A significant factor contributing to the growth of the biosurgery market is the increase in the number of accidents. Accidents, unforeseen events causing harm or injury, occur in various settings such as daily life, workplaces, transportation, and sports. Biosurgery is utilized in accident scenarios to mitigate blood loss, facilitate effective coagulation, and promote wound healing in traumatic situations, injuries, or surgical operations. In 2022, the Department of Infrastructure, Transport, Regional Development, and Communications in Australia reported 1,194 fatal traffic accidents, indicating a 5.8% increase over the previous year. The growth in accident numbers is driving the adoption of biosurgery for effective wound management.

Major companies in the biosurgery market are utilizing technological advancements, particularly in advanced wound care technology, to improve healing outcomes, reduce infection rates, and enhance patient recovery times through innovative products and techniques. Advanced wound care technology includes cutting-edge methods and products aimed at promoting wound healing, preventing infections, and improving overall patient outcomes. For example, in September 2024, Health Care at Home India Pvt Ltd, an India-based manufacturer of medical products, launched the WOW (Warriors of Woundcare) Nurses initiative. This program aims to proactively prevent and treat bedsores, which are common complications for patients with limited mobility. Bedsores can significantly impede recovery, prolong hospital stays, and increase the risk of infections.

Prominent companies in the biosurgery market are increasingly adopting a strategic partnership approach to enhance their capabilities and expand their market presence. Strategic partnerships involve leveraging the strengths and resources of collaborating companies for mutual benefits and success. In a notable example, Biocomposites Ltd., a UK-based manufacturing company specializing in calcium compound solutions for bone and soft tissue regeneration and repair, entered into an agreement with Zimmer Biomet Holdings Inc. in March 2022. Under this agreement, Biocomposites exclusively sells genex Bone Graft Substitute in the US orthopedic market. Genex Bone Graft Substitute is a biphasic composite with excellent purity, precisely developed to balance osteoconductive scaffold toughness and persistence in the body, facilitating optimal bone architecture rebuilding. The partnership includes enhancements for the US market, incorporating a new closed-mixing method to save preparation time and extend working time. It also offers a broader range of delivery options, enabling surgeons to inject, shape, or prepare beads according to their preferred approach.

In June 2022, GTCR LLC, a US-based private equity firm, acquired Barron Precision Instruments, LLC, for an undisclosed amount. This acquisition is part of GTCR LLC's strategy to drive growth and enhance operations within Barron Precision Instruments. Barron Precision Instruments, LLC, is a US-based manufacturer known for producing high-quality medical instruments.

Major companies operating in the biosurgery market include Baxter International Inc., B. Braun SE, Becton, Dickinson and Company, Hemostasis LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., CryoLife Inc., CSL Limited, Pfizer Inc., Zimmer Biomet Holdings Inc., Kuros Biosciences AG, Orthofix Medical Inc., Smiths & Nephew plc, Medtronic plc, Stryker Corp., Betatech Medical, Tissue Regenix Group plc, Aroa Biosurgery Ltd., Anika Therapeutics Inc., Arthrex Inc., B Braun Surgical SA, Biom'Up SA, Boston Scientific Corporation, Coloplast Corp., Cook Medical Inc., Endo International plc, Genzyme Corporation, Takeda Pharmaceutical Company Limited, Cerus Corporation

North America was the largest region in the biosurgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biosurgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biosurgery market consists of revenues earned by entities by providing biosurgery services such as maggot therapy, transplantation, and autologous chondrocyte implantation. The market value includes the value of related goods sold by the service provider or included within the service offering. The biosurgery market also includes sales of absorbable hemostats and surgical sealants which are used in providing biosurgery services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biosurgery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosurgery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosurgery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biosurgery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Bone-Graft Substitutes; Soft-Tissue Attachments; Hemostatic Agents; Surgical Sealants And Adhesives; Adhesion Barriers; Staple Line Reinforcement
  • 2) By Source: Natural Or Biologics Products; Synthetic Products
  • 3) By Application: Orthopedic Surgery; General Surgery; Neurological Surgery; Cardiovascular Surgery; Gynecological Surgery; Other Applications
  • 4) By End-User: Hospitals; Clinics; Other End-Users

Subsegments;

  • 1) By Bone-Graft Substitutes: Synthetic Bone Grafts; Natural Bone Grafts
  • 2) By Soft-Tissue Attachments: Mesh Products; Biological Grafts
  • 3) By Hemostatic Agents: Powdered Agents; Gel-based Agents
  • 4) By Surgical Sealants And Adhesives: Fibrin Sealants; Synthetic Sealants
  • 5) By Adhesion Barriers: Absorbable Barriers; Non-absorbable Barriers
  • 6) By Staple Line Reinforcement: Reinforcement Devices; Surgical Staples
  • Companies Mentioned: Baxter International Inc.; B. Braun SE; Becton, Dickinson and Company; Hemostasis LLC; Integra LifeSciences Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biosurgery Market Characteristics

3. Biosurgery Market Trends And Strategies

4. Biosurgery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Biosurgery Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biosurgery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biosurgery Market Growth Rate Analysis
  • 5.4. Global Biosurgery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biosurgery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biosurgery Total Addressable Market (TAM)

6. Biosurgery Market Segmentation

  • 6.1. Global Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone-Graft Substitutes
  • Soft-Tissue Attachments
  • Hemostatic Agents
  • Surgical Sealants and Adhesives
  • Adhesion Barriers
  • Staple Line Reinforcement
  • 6.2. Global Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural or Biologics Products
  • Synthetic Products
  • 6.3. Global Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Gynecological Surgery
  • Other Applications
  • 6.4. Global Biosurgery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other End-Users
  • 6.5. Global Biosurgery Market, Sub-Segmentation Of Bone-Graft Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Bone Grafts
  • Natural Bone Grafts
  • 6.6. Global Biosurgery Market, Sub-Segmentation Of Soft-Tissue Attachments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mesh Products
  • Biological Grafts
  • 6.7. Global Biosurgery Market, Sub-Segmentation Of Hemostatic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Powdered Agents
  • Gel-based Agents
  • 6.8. Global Biosurgery Market, Sub-Segmentation Of Surgical Sealants And Adhesives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fibrin Sealants
  • Synthetic Sealants
  • 6.9. Global Biosurgery Market, Sub-Segmentation Of Adhesion Barriers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Absorbable Barriers
  • Non-absorbable Barriers
  • 6.10. Global Biosurgery Market, Sub-Segmentation Of Staple Line Reinforcement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reinforcement Devices
  • Surgical Staples

7. Biosurgery Market Regional And Country Analysis

  • 7.1. Global Biosurgery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biosurgery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biosurgery Market

  • 8.1. Asia-Pacific Biosurgery Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biosurgery Market

  • 9.1. China Biosurgery Market Overview
  • 9.2. China Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biosurgery Market

  • 10.1. India Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biosurgery Market

  • 11.1. Japan Biosurgery Market Overview
  • 11.2. Japan Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biosurgery Market

  • 12.1. Australia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biosurgery Market

  • 13.1. Indonesia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biosurgery Market

  • 14.1. South Korea Biosurgery Market Overview
  • 14.2. South Korea Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biosurgery Market

  • 15.1. Western Europe Biosurgery Market Overview
  • 15.2. Western Europe Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biosurgery Market

  • 16.1. UK Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biosurgery Market

  • 17.1. Germany Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biosurgery Market

  • 18.1. France Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biosurgery Market

  • 19.1. Italy Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biosurgery Market

  • 20.1. Spain Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biosurgery Market

  • 21.1. Eastern Europe Biosurgery Market Overview
  • 21.2. Eastern Europe Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biosurgery Market

  • 22.1. Russia Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biosurgery Market

  • 23.1. North America Biosurgery Market Overview
  • 23.2. North America Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biosurgery Market

  • 24.1. USA Biosurgery Market Overview
  • 24.2. USA Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biosurgery Market

  • 25.1. Canada Biosurgery Market Overview
  • 25.2. Canada Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biosurgery Market

  • 26.1. South America Biosurgery Market Overview
  • 26.2. South America Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biosurgery Market

  • 27.1. Brazil Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biosurgery Market

  • 28.1. Middle East Biosurgery Market Overview
  • 28.2. Middle East Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biosurgery Market

  • 29.1. Africa Biosurgery Market Overview
  • 29.2. Africa Biosurgery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biosurgery Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biosurgery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biosurgery Market Competitive Landscape And Company Profiles

  • 30.1. Biosurgery Market Competitive Landscape
  • 30.2. Biosurgery Market Company Profiles
    • 30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. B. Braun SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hemostasis LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Integra LifeSciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Biosurgery Market Other Major And Innovative Companies

  • 31.1. Johnson & Johnson Services Inc.
  • 31.2. CryoLife Inc.
  • 31.3. CSL Limited
  • 31.4. Pfizer Inc.
  • 31.5. Zimmer Biomet Holdings Inc.
  • 31.6. Kuros Biosciences AG
  • 31.7. Orthofix Medical Inc.
  • 31.8. Smiths & Nephew plc
  • 31.9. Medtronic plc
  • 31.10. Stryker Corp.
  • 31.11. Betatech Medical
  • 31.12. Tissue Regenix Group plc
  • 31.13. Aroa Biosurgery Ltd.
  • 31.14. Anika Therapeutics Inc.
  • 31.15. Arthrex Inc.

32. Global Biosurgery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biosurgery Market

34. Recent Developments In The Biosurgery Market

35. Biosurgery Market High Potential Countries, Segments and Strategies

  • 35.1 Biosurgery Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biosurgery Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biosurgery Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer